Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37.
Zhuo. Haiwei H; Zhang. Xi X; Li. Maogen M; Zhang. Qian Q; Wang. Yonglan Y
Key Findings
- KR-12-3 kills S. gordonii in both free‑floating and biofilm forms
- Low doses of KR-12-3 lower IL‑6 and IL‑8 inflammation signals in immune cells
- The peptide shows little toxicity to bone‑forming MC3T3‑E1 cells
Practical Outcomes
- If you’re experimenting with oral health hacks, KR-12-3 points to a promising antimicrobial peptide that might be formulated into a topical gel or rinse for implant care. However, it’s not yet a commercial product, so the immediate takeaway is to watch for future developments or consider it a proof‑of‑concept for peptide‑based anti‑infection strategies.
Summary
Researchers found that a short piece of the natural peptide LL-37, called KR-12-3, can kill the mouth bacteria Streptococcus gordonii and calm down inflammation in lab cells, while staying mostly non‑toxic. This suggests it could become a new kind of mouth rinse or implant coating to prevent gum infection around dental implants, but it’s still early‑stage lab work.
Abstract
Peri-implantitis is a pathological condition involving tissues around dental implants that are characterized by inflammation of the peri-implant mucosa and progressive loss of supporting bone. We found that the antimicrobial peptide KR-12-3 (KRIVKWIKKFLR) derived from LL-37 had antibacterial properties against <i>Streptococcus gordonii</i>. The purpose of this study was to evaluate its antibacterial and anti-inflammatory activities and its underlying mechanisms. We evaluated the antibacterial activities of antimicrobial peptides in planktonic and biofilm states by measuring their minimum inhibitory concentration, minimum bactericidal concentration, and biofilm susceptibility. The effects of antimicrobial peptides on the production of IL-6 and IL-8 in LPS-stimulated RAW264.7 cells were detected by enzyme-linked immunosorbent assay and other experiments, and their toxicity to MC3T3-E1 cells was also studied. While maintaining low cytotoxicity, KR-12-3 exhibited growth inhibitory effects on <i>S. gordonii</i> in planktonic and biofilm states. Lower concentrations of KR-12-3 treatment reduced the production of inflammatory cytokines in LPS-stimulated RAW264.8 cells. The mechanisms underlying the inhibition of biofilm formation and anti-inflammatory effects have been associated with the low expression of related genes. KR-12-3 may be used to develop an antibacterial, anti-infective, and anti-inflammatory drugs for peri-implantitis.
Study Information
pubmed
2022
2022-06-01T00:00:00.000Z
10.3390/antibiotics11060754
22
49